Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M511826200 on November 30, 2005

J. Biol. Chem., Vol. 281, Issue 6, 3586-3594, February 10, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/6/3586    most recent
M511826200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sewell, R.
Right arrow Articles by Taylor-Papadimitriou, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sewell, R.
Right arrow Articles by Taylor-Papadimitriou, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The ST6GalNAc-I Sialyltransferase Localizes throughout the Golgi and Is Responsible for the Synthesis of the Tumor-associated Sialyl-Tn O-Glycan in Human Breast Cancer*

Robert Sewell{ddagger}, Malin Bäckström§1, Martin Dalziel{ddagger}2, Steven Gschmeissner, Hasse Karlsson§, Thomas Noll||3, Jochem Gätgens||, Henrik Clausen**4, Gunnar C. Hansson§1, Joy Burchell{ddagger}, and Joyce Taylor-Papadimitriou{ddagger}5

From the {ddagger}Cancer Research-UK Breast Cancer Biology Group, 3rd Floor, Guy's Hospital, London SE1 9RT, United Kingdom, the §Department of Medical Biochemistry, Göteborg University, 413 90 Gothenburg, Sweden, the Electron Microscopy Unit, Cancer Research-UK London Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom, the ||Institute of Biochemistry Research Center, Juelich GmbH, D-52425 Juelich, Germany, and the **Department of Medical Biochemistry and Genetics Health Science Faculty, University of Copenhagen, DK-2200 Copenhagen, Denmark

The functional properties of glycoproteins are strongly influenced by their profile of glycosylation, and changes in this profile are seen in malignancy. In mucin-type O-linked glycosylation these changes can result in the production of mucins such as MUC1, carrying shorter sialylated O-glycans, and with different site occupancy. Of the tumor-associated sialylated O-glycans, the disaccharide, sialyl-Tn (sialic acid {alpha}2,6GalNAc), is expressed by 30% of breast carcinomas and is the most tumor-specific. The ST6GalNAc-I glycosyltransferase, which can catalyze the transfer of sialic acid to GalNAc, shows a highly restricted pattern of expression in normal adult tissues, being largely limited to the gastrointestinal tract and absent in mammary gland. In breast carcinomas, however, a complete correlation between the expression of RNA-encoding ST6GalNAc-I and the expression of sialyl-Tn is evident, demonstrating that the expression of sialyl-Tn results from switching on expression of hST6GalNAc-I. Endogenous or exogenous expression of hST6GalNAc-I (but not ST6GalNAc-II) always results in the expression of sialyl-Tn. This ability to override core 1/core 2 pathways of O- linked glycosylation is explained by the localization of ST6GalNAc-I, which is found throughout the Golgi stacks. The development of a Chinese hamster ovary (CHO) cell line expressing MUC1 and ST6GalNAc-I allowed the large scale production of MUC1 carrying 83% sialyl-Tn O-glycans. The presence of ST6GalNAc-I in the CHO cells reduced the number of O-glycosylation sites occupied in MUC1, from an average of 4.3 to 3.8 per tandem repeat. The availability of large quantities of this MUC1 glycoform will allow the evaluation of its efficacy as an immunogen for immunotherapy of MUC1/STn-expressing tumors.


Received for publication, November 2, 2005 , and in revised form, November 29, 2005.

* This work was supported in part by Cancer Research-UK, by the European Commission(Grant QLRT-2002-02010), and by the Breast Cancer Campaign (Grant 2000:122). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by Assar Gabrielsson's foundation for cancer research, Lars Hierta's foundation, the Swedish Cancer Foundation, and the Swedish Research Council.

2 Current address: Dept. of Biochemistry, University of Oxford, South Parks Road, OxfordOX1 3QU, United Kingdom.

3 Current address: Faculty of Technology, Universitaet Bielefeld, Universitaetsstrasse 25,P. O. Box 100131, Bielefeld 33501, Germany.

4 Supported by the Danish Cancer Society.

5 To whom correspondence should be addressed: Tel.: 44-20-7188-1472; Fax: 44-20-7188-0919; E-mail: joyce.taylor-papadimitriou{at}cancer.org.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Hilvo, L. Baranauskiene, A. M. Salzano, A. Scaloni, D. Matulis, A. Innocenti, A. Scozzafava, S. M. Monti, A. Di Fiore, G. De Simone, et al.
Biochemical Characterization of CA IX, One of the Most Active Carbonic Anhydrase Isozymes
J. Biol. Chem., October 10, 2008; 283(41): 27799 - 27809.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Tinder, D. B. Subramani, G. D. Basu, J. M. Bradley, J. Schettini, A. Million, T. Skaar, and P. Mukherjee
MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma
J. Immunol., September 1, 2008; 181(5): 3116 - 3125.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Wilkie, G. Picco, J. Foster, D. M. Davies, S. Julien, L. Cooper, S. Arif, S. J. Mather, J. Taylor-Papadimitriou, J. M. Burchell, et al.
Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor
J. Immunol., April 1, 2008; 180(7): 4901 - 4909.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Ju, G. S. Lanneau, T. Gautam, Y. Wang, B. Xia, S. R. Stowell, M. T. Willard, W. Wang, J. Y. Xia, R. E. Zuna, et al.
Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
Cancer Res., March 15, 2008; 68(6): 1636 - 1646.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Valencia, F. Rouzaud, S. Julien, K. G. Chen, T. Passeron, Y. Yamaguchi, M. Abu-Asab, M. Tsokos, G. E. Costin, H. Yamaguchi, et al.
Sialylated Core 1 O-Glycans Influence the Sorting of Pmel17/gp100 and Determine Its Capacity to Form Fibrils
J. Biol. Chem., April 13, 2007; 282(15): 11266 - 11280.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Zhao, T.-L. L. Chen, B. M. Vertel, and K. J. Colley
The CMP-sialic Acid Transporter Is Localized in the Medial-Trans Golgi and Possesses Two Specific Endoplasmic Reticulum Export Motifs in Its Carboxyl-terminal Cytoplasmic Tail
J. Biol. Chem., October 13, 2006; 281(41): 31106 - 31118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement